Today is effectively the final day of ASH but it was still full of information, and to be honest, I’m a bit brain-fried. However, the day was broken up with the opportunity to meet with several Pharma companies: Takeda (Velcade, Ninlaro), who discussed their new Patient Advocacy Liaisons (Oncology Nurses) who will offer presentations to […]
The antibodies are front and center during the 2020 American Society of Hematology’s Annual Meeting. I thought this would be a good time to review the mechanism of action (how they work) of each type of antibody. The first antibodies to make it to the myeloma scene were the monoclonal antibodies. (mAbs) Monoclonal antibodies in […]
2020 has been an unprecedented year in many ways and there have been multiple hardships, but there have also been many positives for me. In April, I celebrated my ten-year anniversary since my multiple myeloma diagnosis, and in August my ten-year “birthday” since my autologous stem cell transplant! When I was diagnosed in 2010, reaching […]
